Biotechnology company
Issues related to drug pricing, including H.R. 1520, the Purple Book Continuity Act; H.R. 1503, the Orange Book Transparency Act; H.R. 1499, the Protecting Consumer Access to Generic Drugs Act; and H.R. 965, the CREATES Act; issues related to Medicare and Medicaid coverage and reimbursement. Issues related to drug pricing, including H.R. 1520, the Purple Book Continuity Act; H.R. 1503, the Orange Book Transparency Act; H.R. 1499, the Protecting Consumer Access to Generic Drugs Act; and H.R. 965, the CREATES Act; issues related to Medicare and Medicaid coverage and reimbursement.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RIVENDELL GROUP LLP
1440 G Street, NW, Washington, DC, 20005, US
MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo)
LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo